Patents by Inventor Ryan PELTO

Ryan PELTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING COPPER METABOLISM-ASSOCIATED DISEASES OR DISORDERS
    Publication number: 20230414654
    Abstract: This disclosure relates to methods of diagnosing and treating a copper metabolism-associated disease or disorder, such as Wilson disease (WD).
    Type: Application
    Filed: November 12, 2021
    Publication date: December 28, 2023
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Pan Wei-Jian, Mark Ma, Brian Meltzer, Eugene Scott Swenson, Scott Edward Mosley, Ryan Pelto, Adam Quicquaro, Guillermo del Angel, Hareesh Chamarthi
  • METHODS OF MEASURING COPPER CONCENTRATION IN BIOLOGICAL SAMPLES
    Publication number: 20220334135
    Abstract: This disclosure relates to methods of measuring copper concentrations in biological samples. More particularly, this disclosure relates to methods of measuring non-ceruloplasmin-bound copper concentrations and/or labile-bound copper concentrations in biological samples. Such methods are particularly useful in management and treatment of metabolism-associated diseases or disorders.
    Type: Application
    Filed: September 11, 2020
    Publication date: October 20, 2022
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Mark Ma, Tao Liang, Ryan Pelto
  • Method for simultaneous quantification of ALXN1210 and eculizumab in human serum or urine
    Patent number: 11112411
    Abstract: Provided herein are methods for simultaneously detecting and quantifying antibodies which bind to the same target and have high sequence identity, such as eculizumab and ALXN1210, present together or alone in a biological sample.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: September 7, 2021
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Meng Chen, Ryan Pelto
  • METHOD FOR SIMULTANEOUS QUANTIFICATION OF ALXN1210 AND ECULIZUMAB IN HUMAN SERUM OR URINE
    Publication number: 20200033364
    Abstract: Provided herein are methods for simultaneously detecting and quantifying antibodies which bind to the same target and have high sequence identity, such as eculizumab and ALXN1210, present together or alone in a biological sample.
    Type: Application
    Filed: March 28, 2018
    Publication date: January 30, 2020
    Inventors: Meng CHEN, Ryan PELTO